***Live: Monday, December 7, 2020 at 2pm EST | 1pm CST | 11am PST***Discover how a North American pharmaceutical company succeeded where dozens of trial sponsors had failed. Leveraging innovative new clinical software, the company helped transition its breakthrough science into trial success, by delivering consistently impeccable data that accelerated the program with far less cost and effort – ultimately leading to a successful submission***On demand available after final airing until Dec. 7, 2021***
Event Overview: In this case study webinar, we explore how a North American pharmaceutical company’s innovative development program for an autoimmune disease treatment succeeded, when more than 30 drugs from other sponsors for the same indication had failed.
The key? Identifying specific medical, operational and logistical risks in the study, and then implementing analytic and workflow tools flexible enough to support tailored risk mitigation strategies – and robust enough to easily and cost-effectively aggregate ALL clinical and operational data from EDC, labs, safety systems, and more into a single unified view, regardless of data type or source. By giving researchers timely, direct access to high-value visualizations and early observations across every aspect of the study, with minimal effort through supporting workflows, the company was able to:
Key Learning Objectives:
Examine the reasons behind the myth that it is too difficult and costly to achieve a single, unified view across a study or program from all clinical and operational data sources
Speaker: Patrick Keenan, Chief Strategist, Prevail InfoWorks
Time and Date: Monday, December 7, 2020 at 2pm EST | 1pm CST | 11am PST
On demand until Dec. 7 2021.
Sponsor: Prevail InfoWorks
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/unified_insight